EANS-Tip Announcement: Marinomed Biotech AG
Quarterly report according to art. 126 Stock Exchange Act
-------------------------------------------------------------------------------- Tip announcement for financial statements transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- The company Marinomed Biotech AG is declaring the following financial reports below: Report Type: Quarterly report according to art. 126 Stock Exchange Act English: Publication Date: 29.11.2019 Publication Location: https://www.marinomed.com/en/investors/publications Further inquiry note: Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at end of announcement euro adhoc --------------------------------------------------------------------------------
issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English
Original content of: Marinomed Biotech AG, transmitted by news aktuell